<?xml version="1.0" encoding="UTF-8"?>
<p>Bacille Calmette– Guérin (BCG), the attenuated form of 
 <italic>M. bovis</italic>, has been used for more than 80 years to protect children against severe forms of TB (
 <xref rid="B45" ref-type="bibr">45</xref>). However, its protective efficacy against pulmonary TB varies from 0 to 80% in adults (
 <xref rid="B46" ref-type="bibr">46</xref>); therefore, a more effective vaccine is needed. Prime-boost could be a good strategy for inducing long-term protection combining BCG with other antigens (
 <xref rid="B47" ref-type="bibr">47</xref>).
</p>
